While the effects that genes in this region have in the HER2+ breast cancer phenotype have been extensively explored, high-throughput technologies that allow genome-wide studies open the possibility for further exploration of the genomic landscape of this pathology. The gene discussed is ERBB2; the disease is breast cancer.